Tumorigenesis and genotoxicity of ethyl carbamate and vinyl carbamate in rodent cells. 1986

J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow

Vinyl carbamate (VC) is a suspect metabolic intermediate in ethyl carbamate (EC) carcinogenesis. In the present studies, EC and VC were evaluated for their relative abilities to induce adenomas and sister chromatid exchanges (SCEs) in lung cells of A/J, C3HeB/FeJ, and C57BL/6J strain mice. For both end points, animals were administered a single i.p. injection of the test chemical. Percentage of mice with adenomas and number of adenomas per mouse were compared among the three strains 24 weeks following exposure to EC or VC. Although the relative order of strain sensitivity was the same for both chemicals: A/J greater than C57BL/6J greater than C3HeB/FeJ, VC was much more potent than EC. For SCE analysis of primary lung cells cultured from treated animals, EC and VC showed potency differences similar to those observed for tumorigenesis. All three mouse strains revealed significant dose-dependent increases in SCE frequency. However, there was no strain specificity for this effect. SCE persistence over time was also compared in treated A/J and C57BL/6J mice. Although EC- and VC-induced SCE frequencies declined over a 2-week observation period, again, there was no strain specificity for this effect. VC was also tested for enhancement of SA7 virus transformation of Syrian hamster embryo cells. Significant concentration-dependent increases in cell transformation frequency were observed.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor
D012854 Sister Chromatid Exchange An exchange of segments between the sister chromatids of a chromosome, either between the sister chromatids of a meiotic tetrad or between the sister chromatids of a duplicated somatic chromosome. Its frequency is increased by ultraviolet and ionizing radiation and other mutagenic agents and is particularly high in BLOOM SYNDROME. Chromatid Exchange, Sister,Chromatid Exchanges, Sister,Exchange, Sister Chromatid,Exchanges, Sister Chromatid,Sister Chromatid Exchanges

Related Publications

J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
May 2010, Drug metabolism reviews,
J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
April 1980, Cancer research,
J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
January 1982, Carcinogenesis,
J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
April 1984, Mutation research,
J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
April 1997, Mutation research,
J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
March 1993, Carcinogenesis,
J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
January 1986, IARC scientific publications,
J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
June 1990, Biochemical and biophysical research communications,
J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
November 1978, Cancer research,
J W Allen, and G D Stoner, and M A Pereira, and L C Backer, and Y Sharief, and G G Hatch, and J A Campbell, and A G Stead, and S Nesnow
July 1998, Carcinogenesis,
Copied contents to your clipboard!